Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | fluid |
|---|---|
| Location: | wickliffe, ohio |
| Users: | 3 |
| Nodes: | 10 (0 / 10) |
| Uptime: | 45:04:59 |
| Calls: | 71 |
| Calls today: | 1 |
| Files: | 15,838 |
| Messages: | 59,987 |